This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Institut Pasteur Korea, Korea Institute of Radiological & Medical Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Jae-Kyung Nam: Innovator in Medical Applications of 2-Methoxyestradiol Derivatives
Introduction
Jae-Kyung Nam is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly through his innovative work on 2-methoxyestradiol derivatives. His research focuses on the treatment and prevention of liver and lung fibrosis, showcasing the potential of these novel compounds in medical applications.
Latest Patents
Jae-Kyung Nam holds 1 patent for his invention titled "2-methoxyestradiol derivatives and medical uses thereof." This patent describes the development of novel 2-methoxyestradiol derivatives and their medical uses. The invention emphasizes the effectiveness of these derivatives in treating or preventing liver or lung fibrosis. Furthermore, it outlines a method for administering an effective amount of these derivatives to achieve therapeutic benefits.
Career Highlights
Throughout his career, Jae-Kyung Nam has worked with prestigious institutions, including Institut Pasteur Korea and the Korea Institute of Radiological & Medical Sciences. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Some of Jae-Kyung Nam's notable coworkers include Haeng Ran Seo and Inhee Choi, who have collaborated with him on various projects. Their combined efforts have further advanced the research in the field of medical applications.
Conclusion
Jae-Kyung Nam's work on 2-methoxyestradiol derivatives represents a significant advancement in the treatment of liver and lung fibrosis. His innovative approach and dedication to medical research continue to inspire future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile